Malignant hypertension and HLA antigens
- 11 December 2008
- journal article
- research article
- Published by Wiley in Tissue Antigens
- Vol. 22 (2) , 155-159
- https://doi.org/10.1111/j.1399-0039.1983.tb01182.x
Abstract
Patients (32) with malignant hypertension and terminal uremia and a group of 1263 healthy blood donors were studied regarding the incidence of different HLA antigens. HLA-Bw35; Cw4 antigens were significantly more frequent in the group of patients with malignant hypertension than in the group of healthy indivdiuals. The frequency of HLA-Bw35 in a group of 60 non-uremic patients with biopsy-proven glomerulonephritis and without malignant hypertension was also studied and found equal to the group of healthy blood donors. There was no overrepresentation of IgA nephritis among the HLA-Bw35 positive patients with glomerulonephritis, but advanced vascular lesions were more common among these than among patients with other HLA antigens.This publication has 15 references indexed in Scilit:
- HLA Antigens in Essential HypertensionTissue Antigens, 2008
- Effect of Cross Reactions on HL-A Antigen ImmunogenicityTissue Antigens, 2008
- IMMUNOLOGICAL CHANGES IN PATIENTS WITH PREVIOUS MALIGNANT ESSENTIAL HYPERTENSIONThe Lancet, 1981
- Human Leucocyte Antigens in Patients with Previous Essential Malignant HypertensionClinical Science, 1980
- HLA-A, -B AND -C ANTIGENS, THEIR SEROLOGY AND CROSS-REACTIONBritish Medical Bulletin, 1978
- Mesangial IgA Glomerulonephritis and HLA AntigensNew England Journal of Medicine, 1978
- HLA-Bw35 and Mesangial IgA GlomerulonephritisNew England Journal of Medicine, 1978
- HL-A ANTIGENS IN ESSENTIAL HYPERTENSIONThe Lancet, 1975
- HISTOLOGICAL DIAGNOSIS OF REJECTION OF RENAL HOMOGRAFTS IN MANThe Lancet, 1967
- Some Different Types Of Essential HypertensionThe Lancet Healthy Longevity, 1939